✦ LIBER ✦

Proteomics in discovery of new markers and toxicity signatures

✍ Scribed by Martina Samiotaki; George Panayotou

Book ID: 119379885
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 58 KB
Volume: 180
Category: Article
ISSN: 0378-4274
DOI: 10.1016/j.toxlet.2008.06.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of proteomics for the discovery of e

Use of proteomics for the discovery of early markers of drug toxicity

✍ Collins, Ben C; Clarke, Ambrose; Kitteringham, Neil R; Gallagher, William M; Pen 📂 Article 📅 2007 🏛 Informa plc 🌐 English ⚖ 430 KB

Use of proteomics in development of biom

Use of proteomics in development of biomarkers and early markers of toxicity

✍ Stephen Pennington; Neil Kitteringham; Rosalind Jenkins; Tony Hunt; Sally Webb; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 85 KB

157 Use of proteomic technologies for di

157 Use of proteomic technologies for discovery of new markers of skin irritation

✍ S.T. Fletcher; V.A. Baker 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Proteomic Approaches in Colon Cancer: Pr

Proteomic Approaches in Colon Cancer: Promising Tools for New Cancer Markers and Drug Target Discovery

✍ Riccardo Alessandro; Claudio Belluco; Elise C. Kohn 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 427 KB

Proteomics of breast cancer for marker d

Proteomics of breast cancer for marker discovery and signal pathway profiling

✍ Hubert Hondermarck; Anne-Sophie Vercoutter-Edouart; Françoise Révillion; Jérôme 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Cancer proteomics and its application to

Cancer proteomics and its application to discovery of therapy response markers in human cancer

✍ Laura Smith; Michael J. Lind; Kevin J. Welham; Lynn Cawkwell; Cancer Biology Pro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract The administration of chemotherapy either alone or in combination with radiotherapy is an important factor in reducing the mortality and morbidity of cancer patients. Resistance to both chemotherapy and radiotherapy represents a major obstacle to a successful outcome. The identification